EISSN 2475-0581

IMPACT FACTOR: 0.6 INDEXED IN SCI EXPANDED INDEXED IN PUBMED

Psychiatry and Clinical Psychopharmacology

35 141 2025

HIGHLY CITED ARTICLES

Resveratrol in Neurodegeneration, in Neurodegenerative Diseases, and in the Redox Biology of the Mitochondria

Danışman et al.

Association Between Mood Disorder Severity, Treatment Response and Systemic Inflammatory Markers: Exploring the Role of NLR, PLR, MLR, and SII

Kucukkarapınar et al.

Experiential Avoidance Process Model: A Review of the Mechanism for the Generation and Maintenance of Avoidance Behavior

Wang et al.

Editorial

COP26 and health: Some progress, but too slow and not enough

Laurie Laybourn-Langton ¹ , Richard Smith ²

Author Affiliation(s)

1.

Senior Adviser, UK Health Alliance on Climate Change

2.

Chair, UK Health Alliance on Climate Change Laybourn-Langton and Smith

Psychiatry and Clinical Psychopharmacology 2022; 32: 1-3

DOI: 10.5152/pcp.2022.222121

Read: 5621 Downloads: 903 Published: 01 March 2022

Volume 32, Issue 1, March 2022

Previous Article

Files